Patient profile & antipsychotic use
MIAMI – Expert clinicians endorsed long-acting injectables as a preferred treatment for bipolar I disorder on the basis of patient characteristics and treatment history, rather than on an assumed level of treatment adherence, according to a small survey.
Survivor, not 'crazy'
WASHINGTON – A view of borderline personality disorder as neurobiological in nature can help clinicians extend their patience and empathy to these notoriously difficult-to-treat patients, according to an expert.
Resilience for doctors: smooth sails
“Changes in medicine have been so frustrating; physicians are at their wits’ end. We don’t recruit people into medicine because they have a skill set for expressing their emotions, or taking care of themselves, or dealing with conflict,” she said. “That’s okay. They can learn it.” That's according to Linda L.M. Worley, MD, staff psychiatrist in the Fayetteville, Ark., Veterans Health Care System and adjunct prof. at Vanderbilt Univ. in Nashville, Tenn.
Psychoanalysis for all
SCOTTSDALE, ARIZ. -- That grumpy grimace is not the face of today's pscyhoanalysis, even if it is the mug of the man who "invented" the notion of using your words as keys to unlock you from your prison of tortuous memory.
Inflamed brains link to depression
SCOTTSDALE, ARIZ. – Inflammation is inextricably linked to depression in a subset of patients who differ from other depressed patients in their responses to certain interventions, according to Charles L. Raison, MD.
Talk therapy for all
SCOTTSDALE, ARIZ. – Most psychiatrists are familiar with many of the basic tenets of psychoanalysis, but they probably aren’t relying on its therapeutic powers in practice as much as they are pharmacotherapy, according to an expert.
Hope for families of mentally ill
WASHINGTON – Bipartisan legislation to improve care of patients with serious mental illness is just a pen stroke from passage, now that the 21st Century Cures Act is headed for the President’s desk.
While the mental health care reform provisions in the legislation (H.R. 34) will impact mental health services broadly, the bulk of the reform language comes from H.R. 2646, a bill sponsored by Rep. Tim Murphy (R-Penn.), which was intended to reverse decades of fragmented – and at times nonexisten
Our BRAIN needs big bucks
BETHESDA, MD – Top researchers are optimistic that billions in funding for basic neuroscience research made possible by the 21st Century Cures Act, will lead to breakthroughs in the understanding of brain function--and dysfunction. Will the discoveries help end the stigma of mental illness?
Depression & measurement-based care
WASHINGTON – Challenging patients with depression to stay engaged in their recovery while rigorously monitoring and measuring their treatment response can mean the difference between remission or resistance, according to an expert.
Can pot smoking trigger psychosis?
Evidence is strong that cannabis use after a first episode of psychosis increases the risk of relapsing psychosis, but causality is still not definite.
Psych + pri-care = future
SCOTTSDALE, ARIZ. – Whether or not the Affordable Care Act (ACA) is repealed, replaced, reviled, or revered should not deter psychiatrists and primary care physicians from seeking to work together, according to a leading expert on integrating mental health care in medical practice.
ECT in elderly curbs depression
AMSTERDAM – Despite persistent stigma, electroconvulsive therapy endures as an effective treatment for depression, particularly when applied with a patient-specific approach, according to several study results presented at the annual congress of the European College of Neuropsychopharmacology.
Mental Health State of the Union
WASHINGTON – Just because mental health parity laws exist, doesn’t mean they are enforced.
ALZ: 'Passing at a cocktail party'
Newtown, Mass. - Steve Johanson was diagnosed with early onset Alzheimer’s disease at age 58. It wasn’t apparent at first, although there were subtle signs and symptoms that in retrospect, an alert physician might have seen. Hear Steve and his wife Judy tell their story and learn ways you can detect memory disorders in patients like Steve.
Dr. Andrew Budson discusses ways you can detect memory disorders in patients like Steve Johanson.
So much to love
BOSTON, Mass. - Boston University’s PAIRS program (Partnering in Alzheimer’s Instruction Research Study) partners medical school students from the University’s medical school with patients who have early stage Alzheimer’s disease or other cognitive impairment. Oscar Garcia, a second year medical school student from El Paso, Tex., was paired with the Johanson family of Watertown, Mass., whose patriarch, Steve Johanson, has been diagnosed with early stage Alzheimer’s. This is their story.
Successful schizophrenia care
CAPITOL HILL -- The young woman on the right, Maggie, age 20, is one of the most intriguing young women with mental illness I have encountered.
At 15, she was at a friend's house having a sleep over. All of a sudden...
IBD specialists turn to psychiatry
PITTSBURGH - In just 1 year, 34 out of about 5,000 patients seen at the inflammatory bowel disease center at the University of Pittsburgh Medical Center cost more than $10 million to treat.
“Our health plan said, ‘You have to fix this,’” recalled Dr. Miguel Regueiro, codirector of the IBD center.
So, in addition to asking the insurer for ideas, Dr. Regueiro did the most cost conscious thing he could think of: He asked for ideas from his colleague, Dr. Eva Szigethy, a psychiatrist specializing
Protecting her husband
WATERTOWN, Mass. -- I was sent to tell a story about a man with early onset Alzheimer's disease. Steve Johanson, 62, had been paired with first year medical school student, Oscar Garcia, 21, as part of an experiential learning program that has shown promise for increasing the heuristic skill sets of future physicians who will one day treat these patients.
The politics of food addiction: who
ATLANTA – It’s too soon to disrupt current obesity treatment by declaring food addiction to be a clinical condition, according to Dr. Paul Fletcher.
"If we are to employ [the term] food addiction ... it needs a firm scientific basis," said Dr. Fletcher, who is the Bernard Wolfe Professor of Health Neuroscience in the department of psychiatry at University of Cambridge (England).
Freud, math, and psychiatry's future
TORONTO – Five in the afternoon, after a full day of cramming one’s brain with information from multiple sessions at an annual medical meeting, is a cruel time to offer a panel discussion linking behavioral economics, Freud, and the RDoC to future treatments for mental disorders.
Psychiatry bible for lay public
TORONTO – The American Psychiatric Association’s consumer guide to the DSM-5, “Understanding Mental Disorders,” debuted at the organization’s annual meeting this year.
Opioid crisis partly fault pri-care
Underlying the nation’s opioid abuse epidemic is the fact that physicians are undertrained, underresourced, and using incorrect assessment tools to diagnose and treat chronic pain, according to an expert panel.
Oxytocin "no go" in schizophrenia
AMSTERDAM – For decades, researchers have studied whether oxytocin has the potential to have a therapeutic effect in schizophrenia. Recently, however, the lack of consistently positive findings has caused some to wonder whether the hormone’s value as a schizophrenia treatment is at a dead end.
First transgender top doc
Before her appointment earlier this year by Gov. Tom Wolf (D-Pa.) as the state’s physician general, Dr. Rachel Levine was vice chair for clinical affairs in the department of pediatrics and chief of the division of adolescent medicine and eating disorders at Penn State Hershey Children’s Hospital at the Penn State Hershey Medical Center. While on the faculty there, she decided to transition from her male birth sex to that of female.